In this episode, Dr. Raj Dash, speaks with Bethany Kalich, a clinical pharmacist and the U.S. Cardiovascular Medical Director at Amgen. The episode centers on setting ambitious health goals and the collaborative efforts needed to achieve significant improvements in cardiovascular health by 2030. It emphasizes the role of technology, real-world evidence, and systemic collaboration in healthcare.

TOPICS DISCUSSED INCLUDE:

• Ambitious Health Goals for 2030: The podcast discusses the target of cutting cardiovascular events in half by 2030, emphasizing the necessity of system-wide collaboration across healthcare providers and pharmaceutical partners to achieve this goal.
• Increasing LDL Testing Rates: There's a focus on doubling the LDL cholesterol testing rates as a critical early milestone, acknowledging its importance as a modifiable risk factor in cardiovascular health.
• Implementation Science and Quality Measures: The episode highlights the role of the Lattice consortium in advancing implementation science to improve LDL testing and goal achievement, and setting quality measures to ensure enhanced care across the system.
• Addressing Disparities in Healthcare: It discusses efforts to ensure equitable access to healthcare interventions, particularly focusing on groups that traditionally face higher burdens of cardiovascular disease.